# Breast Surgery Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Frances Burney (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN013-SYN
- Date: 2026-08-24
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gideon Marsh, MD
- Calendar frame: modern shifted

- Requested by: Harriet Pell, MD

## Reason for consultation

Palpable right breast mass, clinically suspicious for cancer, in a postmenopausal woman of 59. Diagnostic mammography and ultrasound are booked this week, with core biopsy if indicated. Please see her once the results are available to plan surgery. **S**

## History

Mrs. Burney is seen at the request of Dr. Pell with a right breast mass found two months ago, after about a year of a dull, heavy ache in the breast. Diagnostic mammography and ultrasound twelve days ago showed a 2.4 cm spiculated mass at 10 o'clock, BI-RADS 5, with dense breasts and normal axillary nodes. The core biopsy shows invasive ductal carcinoma, grade 2, ER 95 percent, PR 70 percent, HER2 negative. She has no bone pain, cough, headaches, or weight loss. She is postmenopausal and well. She is frightened of surgery and asked to be told in advance of every step, which was agreed. **S**

## Examination

| System | Finding |
|---|---|
| General | Anxious but composed |
| Breasts | Right breast: 2.5 cm hard, irregular mass at 10 o'clock, mobile on the chest wall; no skin dimpling or nipple change; biopsy site bruised. Left breast normal. Breasts small to moderate in size |
| Lymph nodes | No axillary, supraclavicular, or infraclavicular nodes |

BP 132/82 mmHg; pulse 86 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 61.6 kg; BMI 24.1 kg/m². All vital signs are synthetic.

## Data reviewed

Diagnostic mammogram and ultrasound images and reports; core biopsy pathology with ER, PR, HER2, and Ki-67; Dr. Pell's referral and examination; today's PHQ-9 and GAD-7. PHQ-9: 5; GAD-7: 7. All results are synthetic.

## Assessment

1. **Invasive ductal carcinoma of the right breast, clinical T2 N0 M0, hormone receptor positive, HER2 negative** (C50.411). Early-stage cancer suitable for surgery first. Breast-conserving surgery with radiation gives the same survival as mastectomy when the tumor can be removed with clear margins and a good appearance. In dense breasts, MRI can show additional disease that would change that choice. Staging scans are not needed at this stage without symptoms. **S**
2. **Axillary staging**. The axilla is normal on examination and ultrasound, so sentinel lymph node biopsy is the standard; axillary dissection is not needed unless the nodes are heavily involved. **S**
3. **Genetic risk**. Germline testing is recommended for every patient with breast cancer diagnosed at 65 or younger. Her family history is too limited to be reassuring. A pathogenic variant could change the operation, so the result should be known before surgery. **S**
4. **Anesthesia and her fear of surgery**. Her fear is understandable and is best met by clear information. The operation is done under general anesthesia, so she will be asleep and feel nothing; a pectoral nerve block placed before the incision and an opioid-sparing plan usually give good pain control afterwards. **S**

## Recommendations

1. Bilateral breast MRI now for extent of disease; biopsy any additional lesion before deciding on the operation.
2. If the cancer is single and can be removed with a good appearance, breast-conserving surgery with sentinel node biopsy and whole-breast radiation; if there is disease in more than one quadrant, total mastectomy with sentinel node biopsy.
3. Germline multigene panel testing now, with the result before surgery.
4. General anesthesia with an ultrasound-guided pectoral nerve block (PECS II), an enhanced-recovery pathway, scheduled acetaminophen and a short course of ibuprofen, and opioids only if needed; an overnight stay.
5. She will be given the date in advance and a written description of each step of the day, and the anesthesia team will explain each step before it happens.
6. If mastectomy is chosen, a plastic surgery opinion on reconstruction is available; she will decide after the MRI.
7. At the pre-anesthesia visit, baseline arm measurements for later lymphedema checks; after surgery, drain care teaching, and shoulder exercises from the first week.
8. After surgery, a recurrence score on the specimen and a medical oncology review to decide on endocrine therapy, and on chemotherapy or radiation if the pathology calls for them.

## Strengths and supports

- Supports: her husband and son and a wide circle of friends who visit often **S**

## Communication

Discussed with Dr. Pell by telephone today; the patient agrees with the plan and has a written summary of the next steps. **S**

## Follow-up

Breast surgery will review the MRI, any further biopsy, and the genetic result with her within two weeks and set the date of surgery, with a post-operative visit at one week for drain removal and pathology. Primary care continues distress screening and survivorship care. **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025), National Comprehensive Cancer Network
- Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol 2024 (2024), American Society of Clinical Oncology and Society of Surgical Oncology
- CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026), Aether Forge
